Eargo specializes in the design and development of hearing aids.
Eargo has raised $29.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2022.
Eargo's investors include New Enterprise Associates, Patient Square Capital, Maveron, Charles Schwab, Longitude Capital.
Eargo is headquartered in San Jose, United States.
Eargo specializes in the design and development of hearing aids.
Eargo is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Eargo — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/eargo. Accessed July 22, 2026.
VCBacked. (2022). Eargo — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/eargo
{{cite web |title=Eargo — Funding & Investors |url=https://www.vcbacked.co/company/eargo |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated